Skip to main content
Clinical Trials/CTRI/2022/07/043703
CTRI/2022/07/043703
Completed
Phase 4

A COMPARATIVE EVALUATION OF THE EFFECTIVENESS OF CURCUMIN AND NON-CURCUMIN TOOTHPASTE FORMULATION ON GINGIVITIS AND PERIODONTITIS â?? A RANDOMIZED CONTROLLED TRIA

ARUMUGAM P M0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: K053- Chronic periodontitisHealth Condition 2: Z789- Other specified health status
Sponsor
ARUMUGAM P M
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
ARUMUGAM P M

Eligibility Criteria

Inclusion Criteria

  • Patients aged between 25 \- 60yrs.
  • All subjects having gingivitis and periodontitis with a probing pocket depth (PPD) of \>3 mm.
  • All subjects should have at least 20 natural teeth.
  • All subjects need to have a plaque index of greater than 2 as measured by the Turesky et al. (1970\) modification of the Quigley \& Hein plaque index (1962\).
  • All subjects need to be mentally stable.
  • Those who provide written informed consent will be included in the study.
  • No subjects should have undergone any dental treatment in the four\-week period prior to the baseline examination.

Exclusion Criteria

  • Those who are undergoing antibiotic or anti\-inflammatory therapy or on medication for any underlying systemic disorders.
  • History of periodontal therapy in the past 6 months.
  • Inability to participate in the study for its entire duration.
  • Subjects with gross oral pathology are excluded.
  • Female subjects who are either pregnant or taking the contraceptive pill.
  • Subjects who have a history of known sensitivity or oral mucosal tissue reactions to the toothpaste.

Outcomes

Primary Outcomes

Not specified

Similar Trials